Vitamin D Deficiency Linked to Longer Respiratory Support
The prospective cohort study, conducted by researchers from Boston's Massachusetts General Hospital and Harvard Medical School, involved 210 critically ill surgical patients. The research team found that plasma 25-hydroxyvitamin D (25OHD) levels on admission to the surgical ICU were inversely associated with the need for mechanical ventilation in critically ill surgical patients.
Essentially, an optimised vitamin D status is important for ideal musculoskeletal health, regulation of innate and adaptive immunity, and expression of endogenous antimicrobial peptides. Hence, the research team hypothesised that low levels of 25OHD likely contributed to respiratory muscle weakness, systemic inflammation, and infections, which all affect the duration of respiratory support.
However, the researchers said the findings must be interpreted cautiously in view of the observational nature of their study and other limitations.
According to the research team, further studies are needed to validate their findings, to assess potential benefits of aggressive vitamin D supplementation in critical illness, and to identify how vitamin D may reduce the need for mechanical ventilation in surgical ICU patients.
A.S.P.E.N. is dedicated to improving patient care by advancing the science and practice of nutrition support therapy and metabolism. Founded in 1976, A.S.P.E.N. is an interdisciplinary organisation, whose members are involved in the provision of clinical nutrition therapies, including parenteral and enteral nutrition. The society has more than 6,000 members from around the world, including dieticians, physicians, scientists, nurses, nurse practitioners, pharmacists, students, and other health professionals from every facet of nutrition support clinical practice, research and education.
Source: American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
Image Credit: Google Images
Published on : Thu, 8 Jan 2015
Print as PDF
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
17 critical parameters from a blood sample as small as 45 µL Not available in the US When the sample is small but your diagnostic needs are big, the ABL90 FLEX PLUS blood gas analyzer provides critical insights with a turnaround time of less than...
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...
The HAMILTON-C6 represents a new Generation of high-end ventilators. The combination of modularity, ease of use, mobility, and advanced features allows you to individualize your patient's ventilation therapy: - State-of-the-art ventilation modes for adult,...